Search results
The effects of SiPore15 were investigated in people with prediabetes and newly diagnosed Type 2 diabetes. SiPore15 was taken three times a day for 12 weeks. It significantly reduced long-term blood glucose levels and improved other factors related to the disease with minimal side effects.
29 gru 2022 · Taking advantage of silica nanoparticle characteristics such as tuneable particle and pore size, surface chemistry and biocompatibility, silica-based nanocarriers have been developed with the potential to treat diabetes and regulate blood glucose concentration.
2 gru 2021 · The aim of the current study was to confirm that the oral consumption of SiPore15 could safely reduce the long-term blood glucose level and explore the impact of SiPore15 treatment on the improvement of other metabolic parameters in individuals with prediabetes or newly diagnosed T2D.
2 gru 2021 · Engineered mesoporous silica reduces long-term blood glucose and HbA1c, and improves metabolic parameters in prediabetics. December 2021. Nanomedicine 17 (1) DOI: 10.2217/nnm-2021-0235....
1 lut 2024 · Sigrid’s technology uses Silica to slow down digestion, reduce caloric uptake, balance blood sugar, and prevent the development of type 2 diabetes. The effectiveness of the glucose stabilizer in managing blood sugar levels was highlighted, and the conversation touched on the importance of individualized solutions for diabetes management, and ...
Keywords: diabetes prevention •HbA1c medical device mesoporous silica particles prediabetes Type 2 diabetes Prediabetes, also termed ‘intermediate hyperglycemia’, is characterized by blood glucose levels that are above normal but below diabetes threshold (6.1–6.9 mmol/l). Approximately 70–90% of individuals with prediabetes
1 cze 2020 · We have developed unique mesoporous silica particles (MSP) with tailored characteristics (SiPore15) that sequesters pancreatic amylase and lipase locally in the gut, resulting in decreased digestion of carbohydrates and fats.
